2,2'-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,1'-biphenyl>98.0%(GC)(T)1g

L-HISTIDINE HCL, 97%, 5g

Ethyl 4-(3-methoxy-3-oxopropyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate, 95.0%, 250mg

6-Phenyl-5,6,6a,7,8,9,10,10a-octahydro-7,10-methanophenanthridine-2-carboxylic acid, 98%, 250mg

Ethyl 3-(4-methoxyphenyl)propanoate, 95.0%, 1g

N-(4-FLUOROPHENYL)-4-PHENYL-1,3-THIAZOL-2-AMINE, 95%, 10mg

7-Hydroxy-2H-benzo[b][1,4]thiazin-3(4H)-one, 98%, 1g

3,4-Dimethoxy-2-nitrobenzaldehyde, 97%, 250mg

N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-D-lysine, 98+%, 100mg

Buffer solution pH 7.00 0.02 (20 °C), 500 ml, plastic packaging., ready-to-use buffer solution

1-(2-Aminophenyl)-2,2,2-trifluoroethan-1-ol, 95+%, 2.5g

1-N-Boc-2-Piperidinecarbaldehyde, 97.0%, 10g

(1R,2S)-rel-Cyclopropane-1,2-dicarboxylic acid, 95, 250mg